Announcements Trials
Browse Landscape

Phase

Phase NA 45Phase 3 4Phase 4 3Phase 2 2Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Motor Activity 2Weight Loss 1Patient Compliance 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Diet × Clear all
NCT01708824 2016-05-12

Diet and Physical Activity Intervention in CRC Survivors

The University of Hong Kong

Phase 2 Unknown
224 enrolled
Gastrointestinal

Motor Activity, Patient Compliance, Colorectal Neoplasms

NCT02067481 2014-02-20

PREDICOP-F

Institut Català d'Oncologia

Phase 2 Completed
42 enrolled
Breast

Breast Neoplasms, Motor Activity, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡